Literature DB >> 29017963

The role of CXCL12 in tumor microenvironment.

Wenfang Meng1, Shihang Xue2, Ye Chen3.   

Abstract

The chemokine ligand C-X-C motif chemokine ligand 12 (CXCL12) is a kind of small molecules of cytokines that widely expressed in diversified tissues. Recent evidence suggests that CXCL12 plays an important role in the communication of tumor cells with their surrounding microenvironment. The interaction of CXCL12 and its receptors subsequently excite the downstream signaling pathways to affect tumor angiogenesis, tumor cell proliferation and chemoresistance, and thus represents a potential target for cancer therapy. Outpouring molecules targeting CXCL12/CXCR4 axis in tumor microenvironment combined with traditional chemotherapy have drawn more and more attentions, which will be a promising method in anti-cancer therapies. Our review focuses on these roles of CXCL12 and summarizes strategies for treating cancer by disrupting this interaction with special emphasis on the CXCR4/CXCL12 axis.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CXCL12; Tumor cell; Tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 29017963     DOI: 10.1016/j.gene.2017.10.015

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  52 in total

Review 1.  Chemokine signaling in cancer-stroma communications.

Authors:  Arun J Singh; Joe W Gray
Journal:  J Cell Commun Signal       Date:  2021-06-04       Impact factor: 5.782

Review 2.  The Use of Microfluidic Platforms to Probe the Mechanism of Cancer Cell Extravasation.

Authors:  Mark F Coughlin; Roger D Kamm
Journal:  Adv Healthc Mater       Date:  2020-01-29       Impact factor: 9.933

3.  Association of SDF-1 Gene Polymorphism with Increased Risk of Acute Myeloid Leukemia Patients.

Authors:  Doaa Abd Allah M Aladle; Mayada A Ghannam; Shaimaa El-Ashwah; F E I Ghobrial; Metwaly Ibrahim Mortada
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

4.  Expression of CXCL12 in esophageal high grade dysplasia characterized pathologically by lymphocyte accumulation directly under the lesion.

Authors:  Kunio Mochizuki; Naoki Oishi; Toru Odate; Ippei Tahara; Tomohiro Inoue; Kazunari Kasai; Tetsuo Kondo
Journal:  Histol Histopathol       Date:  2021-12-17       Impact factor: 2.303

5.  Cardiovascular disease related circulating biomarkers and cancer incidence and mortality: is there an association?

Authors:  Manol Jovani; Elizabeth E Liu; Samantha M Paniagua; Emily S Lau; Shawn X Li; Katherine S Takvorian; Bernard E Kreger; Greta Lee Splansky; Rudolf A de Boer; Amit D Joshi; Shih Jen Hwang; Chen Yao; Tianxiao Huan; Paul Courchesne; Martin G Larson; Daniel Levy; Andrew T Chan; Jennifer E Ho
Journal:  Cardiovasc Res       Date:  2022-07-27       Impact factor: 13.081

6.  Identification of differentially expressed genes in cervical cancer by bioinformatics analysis.

Authors:  Yanshan Ge; Chaoyang Zhang; Songshu Xiao; Lin Liang; Shan Liao; Yanqi Xiang; Ke Cao; Hongxiang Chen; Yanhong Zhou
Journal:  Oncol Lett       Date:  2018-06-12       Impact factor: 2.967

7.  Adenosine/TGFβ axis in regulation of mammary fibroblast functions.

Authors:  Georgii Vasiukov; Anna Menshikh; Philip Owens; Tatiana Novitskaya; Paula Hurley; Timothy Blackwell; Igor Feoktistov; Sergey V Novitskiy
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

Review 8.  CXCL12 Signaling in the Tumor Microenvironment.

Authors:  Luigi Portella; Anna Maria Bello; Stefania Scala
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Expressions of CXCL12, CXCL10 and CCL18 in Warthin tumors characterized pathologically by having a lymphoid stroma with germinal centers.

Authors:  Kunio Mochizuki; Naoki Oishi; Masataka Kawai; Toru Odate; Ippei Tahara; Tomohiro Inoue; Kazunari Kasai; Tetsuo Kondo
Journal:  Histol Histopathol       Date:  2021-06-14       Impact factor: 2.303

10.  Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice.

Authors:  Yaya Chu; Gaurav Nayyar; Susiyan Jiang; Jeremy M Rosenblum; Patrick Soon-Shiong; Jeffrey T Safrit; Dean A Lee; Mitchell S Cairo
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.